Used in research to study cancer cell signaling pathways, particularly in models of tumor growth and metastasis. Shows activity as a PI3Kβ inhibitor, making it valuable for investigating the role of the PI3K pathway in oncology. Commonly applied in preclinical studies to evaluate targeted therapy approaches, especially in cancers with PTEN deficiency. Also utilized in combination therapy experiments to assess synergistic effects with other anticancer agents.